Welcome to the Oblique Therapeutics partnering page

Committed to advancing productive and collaborative partnerships

Our entrepreneurial, high-science culture in combination with our fast and nimble decision-making makes us the perfect partner for long-lasting and productive relationships.

To maximize the value of our antibody platform AbiProt® and to build on our experience of eight approved and marketed drugs, we seek collaborations with other pharmaceutical and biotechnology companies to create or co-develop antibody products for novel disease targets.

We are highly motivated to build strategic alliances that will help to improve patients’ lives by creating and developing innovative and differentiated antibody-based therapeutics.